Shares of BlossomHill Therapeutics (BLSM) fell on Friday after the cancer drug developer made its trading debut following an upsized initial public offering that raised the company $150M in gross proceeds. - The San Diego, California-based biotech opened at $15.75 during... <
Shares of BlossomHill Therapeutics (BLSM) fell on Friday after the cancer drug developer made its trading debut following an upsized initial public offering that raised the company $150M in gross proceeds. – The San Diego, California-based biotech opened at $15.75 during…
ternoon hours, implying
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.
